Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 13,858 shares at $36.16 ($501K) on 2018-06-11, disclosed to the SEC on 2018-06-12.
Open-market sale of $501k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $6.6M | — | Filing → |